Order Article Reprints

Ferrero MR, Garcia CC, Dutra de Almeida M, Torres Braz da Silva J, Bianchi Reis Insuela D, Teixeira Ferreira TP, de Sá Coutinho D, Trindade de Azevedo C, Machado Rodrigues e Silva P, Martins MA. CCR5 Antagonist Maraviroc Inhibits Acute Exacerbation of Lung Inflammation Triggered by Influenza Virus in Cigarette Smoke-Exposed Mice. Pharmaceuticals. 2021; 14(7):620. https://doi.org/10.3390/ph14070620

Ferrero, Maximiliano Ruben, Cristiana Couto Garcia, Marcella Dutra de Almeida, Jullian Torres Braz da Silva, Daniella Bianchi Reis Insuela, Tatiana Paula Teixeira Ferreira, Diego de Sá Coutinho, Carolina Trindade de Azevedo, Patrícia Machado Rodrigues e Silva, and Marco Aurélio Martins. 2021. "CCR5 Antagonist Maraviroc Inhibits Acute Exacerbation of Lung Inflammation Triggered by Influenza Virus in Cigarette Smoke-Exposed Mice" Pharmaceuticals 14, no. 7: 620. https://doi.org/10.3390/ph14070620

Ferrero, M. R., Garcia, C. C., Dutra de Almeida, M., Torres Braz da Silva, J., Bianchi Reis Insuela, D., Teixeira Ferreira, T. P., de Sá Coutinho, D., Trindade de Azevedo, C., Machado Rodrigues e Silva, P., & Martins, M. A. (2021). CCR5 Antagonist Maraviroc Inhibits Acute Exacerbation of Lung Inflammation Triggered by Influenza Virus in Cigarette Smoke-Exposed Mice. Pharmaceuticals, 14(7), 620. https://doi.org/10.3390/ph14070620